Kallikrein 14 anticorps (N-Term)
Aperçu rapide pour Kallikrein 14 anticorps (N-Term) (ABIN953101)
Antigène
Voir toutes Kallikrein 14 (KLK14) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 14-44, N-Term
-
Specificité
- This antibody recognizes Human KLK14 / Kallikrein-14 (N-term).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogène
- KLH conjugated synthetic peptide between 14-44 amino acids from the N-terminal region of Human KLK14 / Kallikrein-14
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- Kallikrein 14 (KLK14)
-
Autre désignation
- KLK14 / Kallikrein-14
-
Sujet
- Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. An additional transcript variant has been described but its full length nature has not been determined.Synonyms: KLK-L6, KLKL6, Kallikrein-like protein 6
-
Poids moléculaire
- 29122 Da
-
ID gène
- 43847
-
NCBI Accession
- NP_071329
-
Pathways
- Système du Complément, Regulation of G-Protein Coupled Receptor Protein Signaling
Antigène
-